Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

2024's Top Rulings In Native American Law No Photo Available

Crystal Owens

The U.S. Supreme Court this year has handed down rulings with huge price tags attached — from millions in healthcare reimbursement fun... (more story)

Healthcare Hires: Leech Tishman, Weil, Henry Ford Health No Photo Available

Gianna Ferrarin

Full-service law firm Leech Tishman and healthcare boutique Nelson Hardiman announced plans to combine in early October, while Henry F... (more story)

Free Speech Or Bad Medicine? The Abortion 'Reversal' Battle No Photo Available

Dan McKay

The marketing of abortion pill "reversal" — a treatment doubted by medical groups but touted by anti-abortion advocates — is facing in... (more story)